Human leukemia inhibitory factor produced by the expresstec method from rice (Oryza sativa l.) is active in human neural stem cells and mouse induced pluripotent stem cells

Bioengineered

Volumn 5, Issue 3, 2014, Pages 180-185

  Alfano, Randall ^a   Youngblood, Bradford A ^b   Zhang, Deshui ^c   Huang, Ning ^c   MacDonald, Clinton C ^b  

^a InVitria   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c Ventria Bioscience   (United States)

Author keywords

Embryonic stem cell; Growth rate; LIF; Nanog; Oct 4; Recombinant protein expression

Indexed keywords

EMFILERMIN; BIOLOGICAL MARKER; CODON; HOMEODOMAIN PROTEIN; LEUKEMIA INHIBITORY FACTOR; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; BIOLOGICAL ACTIVITY; BIOTECHNOLOGICAL PROCEDURES; CELL DIFFERENTIATION; EXPRESSTEC METHOD; IMMUNOBLOTTING; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CODON; CYTOLOGY; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; PROMOTER REGION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CODON; ESCHERICHIA COLI; GENE EXPRESSION; GLYCOSYLATION; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEUKEMIA INHIBITORY FACTOR; MICE; NEURAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; ORYZA SATIVA; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS;

EID: 84920936953     PISSN: 21655979     EISSN: 21655987     Source Type: Journal    
DOI: 10.4161/bioe.28996     Document Type: Article

References (31)

1. Xu XL, Yi F, Pan HZ, Duan SL, Ding ZC, Yuan GH, Qu J, Zhang HC, Liu GH. Progress and prospects in stem cell therapy. Acta Pharmacol Sin 2013; 34:741-6; PMID:23736002; http://dx.doi.org/10.1038/aps.2013.77
2. Inoue H, Nagata N, Kurokawa H, Yamanaka S. iPS cells: a game changer for future medicine. EMBO J 2014; 33:409-17; PMID:24500035; http://dx.doi.org/10.1002/embj.201387098
3. Harding J, Mirochnitchenko O. Preclinical studies for induced pluripotent stem cell-based therapeutics. J Biol Chem 2014; 289:4585-93; PMID:24362021; http://dx.doi.org/10.1074/jbc.R113.463737
4. Volz KS, Miljan E, Khoo A, Cooke JP. Development of pluripotent stem cells for vascular therapy. Vascul Pharmacol 2012; 56:288-96; PMID:22387745; http://dx.doi.org/10.1016/j.vph.2012.02.010
5. Jeon S, Choi SH, Wolosin JM, Chung SH, Joo CK. Regeneration of the corneal epithelium with conjunctival epithelial equivalents generated in serum-and feeder-cell-free media. Mol Vis 2013; 19:2542-50; PMID:24357922
6. Patrikoski M, Juntunen M, Boucher S, Campbell A, Vemuri MC, Mannerström B, Miettinen S. Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells. Stem Cell Res Ther 2013; 4:27; PMID:23497764; http://dx.doi.org/10.1186/scrt175
7. Belay E. H.R., Schonberger L, Creutzfeldt-Jakob disease surveillance and diagnosis. Dis 2005; 41:834-6
8. Price PBG. Serum-free media for neural cell cultures, in Protocols for neural cell culture, R.A. Fedoroff S, Editor., Humana Press, Inc.: Totowa, NJ. p. 255-263.
9. Steere AN, Bobst CE, Zhang D, Pettit SC, Kaltashov IA, Huang N, Mason AB. Biochemical and structural characterization of recombinant human serum transferrin from rice (Oryza sativa L.). J Inorg Biochem 2012; 116:37-44; PMID:23010327; http://dx.doi.org/10.1016/j.jinorgbio.2012.07.005
10. Kami D, Watakabe K, Yamazaki-Inoue M, Minami K, Kitani T, Itakura Y, Toyoda M, Sakurai T, Umezawa A, Gojo S. Large-scale cell production of stem cells for clinical application using the automated cell processing machine. BMC Biotechnol 2013; 13:102; PMID:24228851; http://dx.doi.org/10.1186/1472-6750-13-102
11. Zhang D, Lee HF, Pettit SC, Zaro JL, Huang N, Shen WC. Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol 2012; 12:92; PMID:23194296; http://dx.doi.org/10.1186/1472-6750-12-92
12. Youngblood BA, Alfano R, Pettit SC, Zhang D, Dallmann HG, Huang N, Macdonald CC. Application of recombinant human leukemia inhibitory factor (LIF) produced in rice (Oryza sativa L.) for maintenance of mouse embryonic stem cells. J Biotechnol 2014; 172:67-72; PMID:24380819; http://dx.doi.org/10.1016/j.jbiotec.2013.12.012
13. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002; 12:432-8; PMID:12220864; http://dx.doi.org/10.1016/S0962-8924(02)02352-8
14. Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development 2009; 136:2311-22; PMID:19542351; http://dx.doi.org/10.1242/dev.024398
15. Barnes J, Lim JM, Godard A, Blanchard F, Wells L, Steet R. Extensive mannose phosphorylation on leukemia inhibitory factor (LIF) controls its extracellular levels by multiple mechanisms. J Biol Chem 2011; 286:24855-64; PMID:21613225; http://dx.doi.org/10.1074/jbc.M111.221432
16. Owczarek CM, Layton MJ, Metcalf D, Lock P, Willson TA, Gough NM, Nicola NA. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant. EMBO J 1993; 12:3487-95; PMID:8253075
17. Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007; 17:42-9; PMID:17211451; http://dx.doi.org/10.1038/sj.cr.7310125
18. Tang Y, Tian XC. JAK-STAT3 and somatic cell reprogramming. JAKSTAT 2013; 2:e24935; PMID:24470976; http://dx.doi.org/10.4161/jkst.24935
19. Hirai H, Firpo M, Kikyo N. Establishment of LIFdependent human iPS cells closely related to basic FGF-dependent authentic iPS cells. PLoS One 2012; 7:e39022; PMID:22720020; http://dx.doi.org/10.1371/journal.pone.0039022
20. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 2010; 107:9222-7; PMID:20442331; http://dx.doi.org/10.1073/pnas.1004584107
21. Piravar Z, Jeddi-Tehrani M, Sadeghi MR, Mohazzab A, Eidi A, Akhondi MM. In vitro Culture of Human Testicular Stem Cells on Feeder-Free Condition. J Reprod Infertil 2013; 14:17-22; PMID:23926556
22. Goharbakhsh L, Mohazzab A, Salehkhou S, Heidari M, Zarnani AH, Parivar K, Akhondi MM. Isolation and culture of human spermatogonial stem cells derived from testis biopsy. Avicenna J Med Biotechnol 2013; 5:54-61; PMID:23626877
23. Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, Mundy WR, Wei L, Dhara SK, Stice SL. Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells 2012; 30:2387-99; PMID:22899336; http://dx.doi.org/10.1002/stem.1201
24. Atari M, Gil-Recio C, Fabregat M, García-Fernández D, Barajas M, Carrasco MA, Jung HS, Alfaro FH, Casals N, Prosper F, et al. Dental pulp of the third molar: a new source of pluripotent-like stem cells. J Cell Sci 2012; 125:3343-56; PMID:22467856; http://dx.doi.org/10.1242/jcs.096537
25. Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 2010; 8:564-87; PMID:20233335; http://dx.doi.org/10.1111/j.1467-7652.2009.00497.x
26. Zhang D, Nandi S, Bryan P, Pettit S, Nguyen D, Santos MA, Huang N. Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.). Protein Expr Purif 2010; 74:69-79; PMID:20447458; http://dx.doi.org/10.1016/j.pep.2010.04.019
27. Farran I, Sánchez-Serrano JJ, Medina JF, Prieto J, Mingo-Castel AM. Targeted expression of human serum albumin to potato tubers. Transgenic Res 2002; 11:337-46; PMID:12212837; http://dx.doi.org/10.1023/A:1016356510770
28. Zhang D. Plant seed-derived human transferrin: expression, characterisation and applications. OA Biotechnology 2013; 2:17; http://dx.doi.org/10.13172/2052-0069-2-2-580
29. Huang J. Expression of natural antimicrobial human lysozyme in rice grains. Mol Breed 2002; 10: 83-94; http://dx.doi.org/10.1023/A:1020355511981
30. Huang N. Y.D., ExpressTec: high level expression of biopharmaceuticals in cereal grain. In: Knablein J (ed) Modern Biopharmaceuticals; Design, Development and Optimization, Wiley-Vch 2005: p. 931-47.
31. Pettit S. S.M., Tanner T, Huang N, Enhanced growth and productivity of hybridoma with recombinant human serum albumin and lactoferrin. BioProcessing J 2009; 8:50-5